Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-Driven Drug Discovery and Disease Diagnosis
Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer's global network of LifeHubs designed to accelerate the co-exploration and development of pioneering solutions to solve global challenges in health and nutrition.
Read more ...
The Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection with the Aim of Accelerating Diagnosis
The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib) with the aim of improving earlier detection in individuals at increased risk of stroke.
Read more ...
The Berlin-based digital health platform Heartbeat Labs hired Chad Jennings as Chief Product Officer (CPO). Chad is a product and design leader with twenty years of experience at the intersection of product, design, brand, user experience, and technology.
Read more ...
Almirall Takes a Leap into Dermatology Digital Health Innovation
Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme called the Digital Garden, powered by Almirall and strengthens the company's commitment to digital innovation based on developing services and solutions to tackle some of the present and future dermatological challenges.
Read more ...
Abbott and Omada Health Partner to Offer Integrated Digital Health and Coaching Experience for People with Type 2 Diabetes
Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) technology, with Omada Health's pioneering digital care program, aiming to create a new paradigm for people with Type 2 diabetes.
Read more ...
Cerner CEO Unveils Next-Generation Cognitive Platform in Health Conference Keynote
During his keynote at Cerner Health Conference (CHC), the company's Chairman and CEO, Brent Shafer, unveiled a next-generation cognitive health platform, introduced new tools that allow the company's clients to get more from Cerner technology, announced new predictive modeling built directly into the opioid toolkit and opened up free access to the company's training modules.
Read more ...
Bayer Inks Deals with Eleven Startups under G4A Digital Health Partnerships Program
Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations to drive forward the development of specific digital solutions to improve patients' health in the fields of cardiovascular diseases, oncology, ophthalmology, pulmonology, radiology as well as digital therapeutics.
Read more ...
Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer's global network of LifeHubs designed to accelerate the co-exploration and development of pioneering solutions to solve global challenges in health and nutrition. 
The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib) with the aim of improving earlier detection in individuals at increased risk of stroke. 
The Berlin-based digital health platform Heartbeat Labs hired Chad Jennings as Chief Product Officer (CPO). Chad is a product and design leader with twenty years of experience at the intersection of product, design, brand, user experience, and technology. 
Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme called the Digital Garden, powered by Almirall and strengthens the company's commitment to digital innovation based on developing services and solutions to tackle some of the present and future dermatological challenges. 
Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) technology, with Omada Health's pioneering digital care program, aiming to create a new paradigm for people with Type 2 diabetes. 
During his keynote at Cerner Health Conference (CHC), the company's Chairman and CEO, Brent Shafer, unveiled a next-generation cognitive health platform, introduced new tools that allow the company's clients to get more from Cerner technology, announced new predictive modeling built directly into the opioid toolkit and opened up free access to the company's training modules.